Therefore, the present study was carried out with the aim of determining the proportion of individuals with low serum IGF-1 levels and/or failing to respond to the combined GH-releasing hormone (GHRH) plus arginine test in a cohort of FM subjects with severe obesity. The gene discussed is GHRH; the disease is obesity due to melanocortin 4 receptor deficiency.